Literature DB >> 22232753

Optimizing drug development and use in patients with kidney disease: opportunities, innovations, and challenges.

Marc Pfister, Thomas D Nolin, Vikram Arya.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22232753     DOI： 10.1177/0091270011415414

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  2 in total

Review 1.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Authors:  Frederique Rodieux; Melanie Wilbaux; Johannes N van den Anker; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

Review 2.  A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directions.

Authors:  Jim J Xiao; Jiyun S Chen; Bert L Lum; Richard A Graham
Journal:  Anticancer Drugs       Date:  2017-08       Impact factor: 2.248
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.